cytarabine and palbociclib

cytarabine has been researched along with palbociclib in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Boyson, CA; Chen-Kiang, S; Di Liberto, M; Dorn, DC; Hannah, J; Huang, X; Moore, MA; Yang, C; Zhou, P	1
Du, J; Fang, P; Liang, H; Liu, W; Zeng, H; Zhang, K; Zhao, L; Zhao, T; Zhou, C	1

Other Studies

2 other study(ies) available for cytarabine and palbociclib

Article	Year
CDK4/6 Inhibitor PD 0332991 Sensitizes Acute Myeloid Leukemia to Cytarabine-Mediated Cytotoxicity. Cancer research, 2015, May-01, Volume: 75, Issue:9 Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Cytarabine; DNA Damage; DNA Replication; HEK293 Cells; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Mice, Inbred NOD; Mice, SCID; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-pim-1; Pyridines; S Phase; Transcription, Genetic; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2015
GLI1 reduces drug sensitivity by regulating cell cycle through PI3K/AKT/GSK3/CDK pathway in acute myeloid leukemia. Cell death & disease, 2021, 03-03, Volume: 12, Issue:3 Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cell Proliferation; Cyclin-Dependent Kinases; Cytarabine; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Leukemic; Glycogen Synthase Kinase 3; HEK293 Cells; Humans; Leukemia, Myeloid, Acute; Mice, Nude; Phosphatidylinositol 3-Kinase; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyridines; Pyrimidines; Signal Transduction; THP-1 Cells; Tumor Burden; U937 Cells; Xenograft Model Antitumor Assays; Zinc Finger Protein GLI1	2021

Article

Year

CDK4/6 Inhibitor PD 0332991 Sensitizes Acute Myeloid Leukemia to Cytarabine-Mediated Cytotoxicity.

Cancer research, 2015, May-01, Volume: 75, Issue:9

Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Cytarabine; DNA Damage; DNA Replication; HEK293 Cells; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Mice, Inbred NOD; Mice, SCID; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-pim-1; Pyridines; S Phase; Transcription, Genetic; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2015

GLI1 reduces drug sensitivity by regulating cell cycle through PI3K/AKT/GSK3/CDK pathway in acute myeloid leukemia.

Cell death & disease, 2021, 03-03, Volume: 12, Issue:3

Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cell Proliferation; Cyclin-Dependent Kinases; Cytarabine; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Leukemic; Glycogen Synthase Kinase 3; HEK293 Cells; Humans; Leukemia, Myeloid, Acute; Mice, Nude; Phosphatidylinositol 3-Kinase; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyridines; Pyrimidines; Signal Transduction; THP-1 Cells; Tumor Burden; U937 Cells; Xenograft Model Antitumor Assays; Zinc Finger Protein GLI1

2021